A Legacy Proven by Science, Defined by Achievement
Years of dedicated research and responsible innovation have shaped today's GeneChem
A Legacy Proven
by Science, Validated
by Achievement
Years of dedicated research and responsible innovation have shaped today's GeneChem
Raised $15 million in funding (2025)
Launched Sialyllactose-based brand Siallac® (2024)
Developed 8 rare HMOs(2024)
Received U.S. Non-GMO certification for Sialyllactose (2023)
Awarded Korea Excellent Patent Prize (Biotechnology) and obtained HALAL certification (2023)
Secured Kosher certification
for Sialyllactose (2023)
Achieved Industrial LMO approval and FSSC 22000 certification for Sejong Plant (2022–2023)
Acquired by Soulbrain Holdings Co., Ltd. (2021)
Received Presidential Citation for Excellence in Materials, Parts & Equipment (2020)
Named one of Korea’s Top 100 Small Giant Companies (2020)
Filed and received FDA GRAS approval for 3’-Sialyllactose (2018)
Achieved U.S. Self-Affirmed GRAS
for 3’- and 6’-Sialyllactose (2017)
